SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)
Clinical trial NCT00783393 · COMPLETED
Trial details
- NCT number
- NCT00783393
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-27
- Primary completion
- 2005-06-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.